Pharmaceutical News and Articles

Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina

Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, rese

Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will

Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death

The weight-loss drug Ozempic can help reduce stroke patients risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 di

Report Finds Big Disparities in Americans' Well-Being by Region

Americans well-being varies widely between different regions of the nation, a new study reports. People in the southern U.S., Appalachia and the Rust Belt state

Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma

On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as Leads Biolabs ) announced that LBL-034, a humanized bispecific T-cell engaging antibo

JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma

SHANGHAI, NANJING, and SAN JOSE, CA., November 07, 2024 IASO Biotherapeutics ( IASO Bio ), a biopharmaceutical company dedicated to discovering, developing, man

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

American College of Gastroenterology, Oct. 25-30

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted participants from around the world, inc

Racial, Ethnic Differences Seen in Cleft Lip Surgery Repair

Racial and ethnic differences are seen with primary cleft lip surgery repair, according to a study published online in the November issue of Plastic and Reconst

Men Aged >16 to to <55 years at increased risk for acute kidney injury (AKI)

Boys and men aged 16 to 55 years have an increased risk for acute kidney injury (AKI) during hospitalization, according to a study published online Oct. 22 in t